Biomed Central Ltd

SHERPA: Unknown

People

  1. Park
    Park
  2. O'Reilly
    O'Reilly

Groups

  1. CTCR Scholars (9)
  2. Center for Pancreatic Cancer Research (9)
  3. Department of Medicine (9)
  4. Gastrointestinal Oncology Service (9)
  5. MSK Grad Students (9)
  6. Master of Science in Clinical and Translational Cancer Research (9)
  7. Solid Tumor Oncology Division (9)
  8. Sloan Kettering Institute Postdocs (2)
Search Within
  1. "Wungki Park"
Formats
  1. Meeting Abstract (7)
  2. Journal Article (1)
  3. Review (1)
Groups
  1. CTCR Scholars (9)
  2. Center for Pancreatic Cancer Research (9)
  3. Department of Medicine (9)
  4. Gastrointestinal Oncology Service (9)
  5. MSK Grad Students (9)
  6. Master of Science in Clinical and Translational Cancer Research (9)

More Groups

People
  1. Wungki Park (9)
  2. Roberta Zappasodi (2)
  3. Diego Chowell Puente (1)
  4. Eileen O'Reilly (1)
Years
  1. 2023 (1)
  2. 2022 (1)
  3. 2020 (4)
  4. 2019 (2)
  5. 2018 (1)
Publications
  1. Journal for ImmunoTherapy of Cancer (9)

Results (9)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden
    Journal Article

    Florou, V.; Floudas, C. S.; Maoz, A.; Naqash, A. R.; Norton, C.; Tan, A. C.; Sokol, E. S.; Frampton, G.; Soares, H. P.; Puri, S.; more...
    Journal for ImmunoTherapy of Cancer (2023)

    Fulltext@MSK | Save
  • Generalizability of predictive versus prognostic indicators from published transcriptomic associations with tumor response to immune checkpoint inhibition
    Meeting Abstract

    Bortone, D.; Monette, A.; Tschernia, N.; Cogdill, A.; Najjar, Y.; Sweis, R. F.; Valpione, S.; Wennerberg, E.; Bommareddy, P.; Haymaker, C.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Combining transcriptomic- and tissue-based immune biomarkers to evaluate GB1275, a CD11b modulator, as a single agent or with pembrolizumab in patients with advanced solid tumors
    Meeting Abstract

    Messersmith, W.; Rasco, D.; De Bono, J.; Wang-Gillam, A.; Park, W.; Nickle, D.; Galkin, A.; Ferguson, B.; Carter, L.; Zhou, L.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Preliminary results from Keynote-A36, a study of GB1275, a first-in-class oral CD11b modulator, alone and with pembrolizumab or chemotherapy in specified advanced solid tumors
    Meeting Abstract

    Bendell, J.; Messersmith, W.; Rasco, D.; Wang-Gillam, A.; Park, W.; Zhou, L.; Carter, L.; Bruey, J. M.; Li, J.; Ferguson, B.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Generalizability of potential biomarkers of response to CTLA-4 and PD-1 blockade therapy in cancer
    Meeting Abstract

    Bortone, D.; Vensko, S.; Entwistle, S.; Cogdill, A.; Monette, A.; Najjar, Y.; Sweis, R.; Tschernia, N.; Wennerberg, E.; Bommareddy, P.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Construction of the immune landscape of durable response to checkpoint blockade therapy by integrating publicly available datasets
    Meeting Abstract

    Rudqvist, N. P.; Zappasodi, R.; Wells, D.; Thorsson, V.; Cogdill, A.; Monette, A.; Najjar, Y.; Sweis, R.; Wennerberg, E.; Bommareddy, P.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • A phase 1/2 study of GB1275, a novel CD11b modulator, as monotherapy and with an anti-PD-1 antibody in specified advanced solid tumors or with chemotherapy in metastatic pancreatic cancer (mPDAC)
    Meeting Abstract

    Bendell, J.; Rasco, D.; Park, W.; Zhou, L.; Galkin, A.; Slee, D.; Carter, L.; Nickle, D.; Tran, R.; Li, J.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Toward a comprehensive view of cancer immune responsiveness: A synopsis from the SITC workshop
    Review

    Bedognetti, D.; Ceccarelli, M.; Galluzzi, L.; Lu, R.; Palucka, K.; Samayoa, J.; Spranger, S.; Warren, S.; Wong, K. K.; Ziv, E.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Frameshift indel selectively correlates with immunotherapy outcome for advanced NSCLC
    Meeting Abstract

    Park, W.; Park, L. C.; Florou, V.; Saravia, D.; Chang, S.; Wang, S.; Chiec, L.; Rahbari, A.; Viveiros, P.; Sukhadia, B.; more...
    Journal for ImmunoTherapy of Cancer (2018)

    Fulltext@MSK | Save